九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02566 九源基因

休市中 10-16 16:08:14

5.230

+0.030

+0.58%

最高5.300	最低5.200	成交量3.16万
今开5.205	昨收5.200	日振幅1.92%
总市值12.40亿	流通市值12.40亿	总股本2.37亿
成交额16.55万	换手率0.01%	流通股本2.37亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":5.23,"timestamp":1792138094408,"preClose":5.2,"halted":0,"volume":31600,"delay":0,"changeRate":0.005769230769230817,"floatShares":237000000,"shares":237000000,"eps":0.6619820311256562,"marketStatus":"休市中","change":0.03,"latestTime":"10-16 16:08:14","open":5.205,"high":5.3,"low":5.2,"amount":165495,"amplitude":0.019231,"askPrice":5.32,"askSize":2000,"bidPrice":5.23,"bidSize":3200,"shortable":0,"etf":0,"ttmEps":0.6720559871212298,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":7,"adr":0,"listingDate":1732723200000,"exchange":"SEHK","adjPreClose":5.2,"dividendRate":0.012775,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":0.205569,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02566","defaultTab":"news","newsList":[{"id":"2675359759","title":"九源基因(02566.HK)10月13日耗资154.57万港元回购26.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675359759","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675359759?lang=zh_cn&edition=full","pubTime":"2026-10-13 19:47","pubTimestamp":1791892024,"startTime":"0","endTime":"0","summary":"格隆汇10月13日丨九源基因(02566.HK)公告，10月13日耗资154.57万港元回购26.66万股，每股回购价格5.79-5.8港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261013/32395653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178912515","title":"九源基因回购26.66万股股份，总额约154.57万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178912515","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178912515?lang=zh_cn&edition=full","pubTime":"2026-10-13 19:12","pubTimestamp":1791889944,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年10月13日发布公告，披露在香港联交所场内回购股份事宜。本次回购数量为266,600股，占当日公司现有已发行股本约0.11232%。每股回购价格介乎每股5.79港元至5.80港元，平均价格约每股5.798港元，总涉资约1,545,702港元。截至目前公司已回购4,415,000股，剩余可回购股数为19,736,640股。公司在公告中确认，本次回购行为已经董事会正式授权，遵循香港联交所证券上市规则及相关法律法规进行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因回购26.66万股股份，总额约154.57万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138100623","title":"九源基因10月12日回购45.84万股，耗资约261.33万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138100623","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138100623?lang=zh_cn&edition=full","pubTime":"2026-10-12 19:42","pubTimestamp":1791805332,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年10月12日发布翌日披露报表，公布公司于同日通过香港联交所场内回购H股的最新进展。公告显示，公司于10月12日回购45.84万股H股，占当日该类股份已发行股本约0.19275%，每股回购价介乎5.68港元至5.75港元，总耗资约261.33万港元。另据公告，公司于2026年6月15日通过最高可回购24,151,640股的授权。截至本次回购，累计已回购4,148,400股，占该授权总量的1.71765%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因10月12日回购45.84万股，耗资约261.33万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674721688","title":"九源基因(02566)10月12日斥资261.3万港元回购45.84万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674721688","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674721688?lang=zh_cn&edition=full","pubTime":"2026-10-12 19:40","pubTimestamp":1791805231,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，于2026年10月12日斥资261.3万港元回购45.84万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172890470","title":"九源基因10月8日回购51.38万股股份，涉资约288.95万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172890470","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172890470?lang=zh_cn&edition=full","pubTime":"2026-10-08 21:06","pubTimestamp":1791464787,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年10月8日公告，披露公司当日于香港联交所场内回购合计513,800股H股普通股，占该交易前已发行股份总数约0.21557%。回购价格介乎每股港币5.456元至5.65元，合计支付对价2,889,486港元，折合约288.95万港元。本次回购完成后，公司已发行股份数量由238,340,200股下降至237,826,400股，同时库藏股由7,058,600股增至7,572,400股。据悉，根据有关规定，在本次回购完成后三十日内，公司不得再进行新股发行或出售、转让库藏股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因10月8日回购51.38万股股份，涉资约288.95万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673070390","title":"九源基因(02566)10月8日斥资288.95万港元回购51.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673070390","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673070390?lang=zh_cn&edition=full","pubTime":"2026-10-08 21:04","pubTimestamp":1791464641,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，于2026年10月8日，该公司斥资288.95万港元回购51.38万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136689422","title":"九源基因2026年9月股份变动月报：股本维持245,398,800股","url":"https://stock-news.laohu8.com/highlight/detail?id=1136689422","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136689422?lang=zh_cn&edition=full","pubTime":"2026-10-07 19:11","pubTimestamp":1791371513,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年10月7日发布截至2026年9月30日止的证券变动月报表。本月公司注册股本保持人民币245,398,800元，已发行股份总数亦维持245,398,800股。其中，普通股H股的上月底结存为240,290,000股，期末则为238,340,200股；公司在报告期末的库藏股数量从5,108,800股增加至7,058,600股。本期主要变动源于当月多次股份回购：9月内合计购回约1,949,800股H股并将其置于库藏股份，其中9月28日回购金额最高，涉及1,382,400股，回购价格为每股港币5.777元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670177237","title":"九源基因(02566.HK)9月28日斥资798.55万港元回购138.24万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670177237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670177237?lang=zh_cn&edition=full","pubTime":"2026-09-28 20:40","pubTimestamp":1790599211,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192170005","title":"九源基因9月28日回购138.24万股H股，耗资约798.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192170005","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192170005?lang=zh_cn&edition=full","pubTime":"2026-09-28 19:36","pubTimestamp":1790595390,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年9月28日公告称，当日于香港联交所场内回购H股，回购股份总数1,382,400股，占回购前公司已发行股本约0.57667%。本次回购价格区间介乎每股5.685港元至5.83港元，合计耗资7,985,475港元。根据披露，公司于2026年6月15日通过相关回购授权，可回购股份总数为24,151,640股，截至目前已在香港联交所或其他证券交易所购回3,176,200股，占购回授权通过当日已发行股本约1.31511%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因9月28日回购138.24万股H股，耗资约798.55万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135929778","title":"九源基因9月24日回购10.18万股股份，耗资约56.81万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135929778","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135929778?lang=zh_cn&edition=full","pubTime":"2026-09-24 20:30","pubTimestamp":1790253058,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年9月24日公告翌日披露报表，宣布当日在香港联交所场内以每股5.50港元至5.70港元的价格回购H股普通股101,800股，合计耗资约568,063港元，占2026年9月17日公司已发行股本约0.04245%。九源基因此前于2026年6月15日通过回购授权，可回购股份总数24,151,640股。九源基因在公告中确认，本次回购严格遵循香港联交所上市规则及相关法律法规要求，并将继续履行信息披露义务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"九源基因9月24日回购10.18万股股份，耗资约56.81万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669498814","title":"九源基因(02566)9月24日斥资56.81万港元回购10.18万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669498814","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669498814?lang=zh_cn&edition=full","pubTime":"2026-09-24 20:27","pubTimestamp":1790252857,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)发布公告，于2026年9月24日，该公司斥资56.81万港元回购10.18万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170622049","title":"九源基因（02566）2026年中期营收6.31亿元，经调整净利润0.91亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170622049","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170622049?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:42","pubTimestamp":1790152920,"startTime":"0","endTime":"0","summary":"九源基因发布2026年中期财报，报告期内，公司实现营收6.31亿元，同比下降1.2%；经调整净利润0.91亿元，同比增长1.2%。毛利率为81.1%，较上年同期的82.2%略有下降。经营活动所得现金流达到1.07亿元，较上年同期的0.13亿元有显著提升。公司保持了稳健的盈利能力，同时研发投入较上年同期有所增加，研发费用达0.69亿元。销售及市场开支为3.15亿元，较上年同期下降约8.9%，反映出公司成本管控趋于优化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"九源基因（02566）2026年中期营收6.31亿元，经调整净利润0.91亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162690383","title":"九源基因（02566）2026年首场临时股东大会通过两项议案 投票赞成率均达100%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162690383","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162690383?lang=zh_cn&edition=full","pubTime":"2026-09-18 21:45","pubTimestamp":1789739133,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司9月18日公告披露，公司于2026年9月18日召开2026年第一次临时股东大会，各项议案均以全票通过。本次临时股东大会以现场方式在浙江省杭州市举行，由董事会主席傅航主持。会议召集和召开程序符合中国法律法规、香港联合交易所有限公司证券上市规则及公司章程的相关规定。现场及授权代表合计1名股东出席会议，持有110,601,750股股份，占有表决权股份总数的约46.12%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101883867","title":"九源基因回购23.68万股股份，涉资约131.64万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101883867","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101883867?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:21","pubTimestamp":1789644068,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年9月17日在香港联交所披露翌日披露报表，宣布当日于联交所场内执行了H股回购操作。公告显示，此次公司共回购236,800股H股，占回购前公司已发行股本的0.09856%，每股回购价格在港币5.499至5.600港元之间，合计支付约131.64万港元。公司确认，本次回购已获董事会授权并严格遵守香港联交所主板上市规则和相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因回购23.68万股股份，涉资约131.64万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135444871","title":"九源基因（02566）9月16日回购20.52万股股份，总额约112.86万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135444871","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135444871?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:56","pubTimestamp":1789559787,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年9月16日发布翌日报表公告，披露公司在香港联交所场内回购股份的最新进展。根据公告，九源基因当日回购20.52万股股份，占该公司回购前已发行股份总数约0.08541%。本次回购的每股价格介于港币5.465元至港币5.50元之间，合计付款金额约为港币112.86万元。本次回购根据公司于2026年6月15日通过的购回授权进行，授权可回购的股份总数为24,151,640股。本公告由九源基因联席公司秘书黄秀签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"九源基因（02566）9月16日回购20.52万股股份，总额约112.86万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988680","title":"九源基因(02566.HK)9月16日斥资112.86万港元回购20.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988680","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667988680?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:51","pubTimestamp":1789559516,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157969641","title":"九源基因9月15日回购3,600股，涉资19,359港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157969641","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157969641?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:50","pubTimestamp":1789473055,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年9月15日发布公告，披露最新股份购回事宜。公告显示，九源基因于9月15日通过香港联交所场内回购H股3,600股，占该公司已发行股本约0.0015%，回购价格区间介乎每股5.20港元至5.40港元，合计支付金额19,359港元。回购完成后，九源基因已发行股份变动为240,266,400股，库存股份增至5,132,400股，公司总股本仍为245,398,800股。根据公告，该次回购已取得公司于2026年6月15日通过的回购授权，最高允许回购24,151,640股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"九源基因9月15日回购3,600股，涉资19,359港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667446506","title":"九源基因(02566.HK)9月15日斥资1.94万港元回购3600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667446506","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667446506?lang=zh_cn&edition=full","pubTime":"2026-09-15 19:47","pubTimestamp":1789472833,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02566","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188494302","title":"九源基因9月11日回购2万股，耗资约10.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188494302","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188494302?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:32","pubTimestamp":1789126351,"startTime":"0","endTime":"0","summary":"杭州九源基因生物医药股份有限公司于2026年9月11日披露翌日披露报表，宣布当日在香港联交所场内回购普通股H股2万股，占回购前现有已发行股份约0.00832%。本次回购最高价为每股5.395港元，最低价为每股5.23港元，合计耗资约10.60万港元。回购完成后，公司已发行股份总数仍为245,398,800股，其中已发行且不包括库藏股的股份数量降至240,270,000股，库存股增至5,128,800股。九源基因方面确认，本次回购符合香港联交所证券上市规则及相关法律法规，已履行必要的审批程序。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"九源基因9月11日回购2万股，耗资约10.60万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529970","title":"九源基因(02566.HK)9月11日斥资10.6万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529970","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666529970?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:13","pubTimestamp":1789125185,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02566"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-gene.com","stockEarnings":[{"period":"1week","weight":-0.0719},{"period":"1month","weight":-0.0491},{"period":"3month","weight":-0.1254},{"period":"6month","weight":-0.2622},{"period":"1year","weight":-0.4613},{"period":"ytd","weight":-0.3003}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州九源基因生物医药股份有限公司（原名：杭州九源基因工程股份有限公司）是一家主要从事研发、生产及商业化生物药品和医疗器械的中国公司。该公司专注于骨科、代谢疾病、肿瘤及血液治疗领域。该公司的骨科产品包括骨优导骨修复材料。该公司的肿瘤产品包括吉利芬、吉巨芬、吉欧停、吉芙惟、吉坦苏。该公司的血液产品包括吉派林、亿喏佳。该公司的产品主要用于治疗糖尿病、多发性骨髓瘤、血小板减少症、中性粒细胞减少症等疾病。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"九源基因","nameEN":"JIUYUAN GENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九源基因,02566,九源基因股票,九源基因股票老虎,九源基因股票老虎国际,九源基因行情,九源基因股票行情,九源基因股价,九源基因股市,九源基因股票价格,九源基因股票交易,九源基因股票购买,九源基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}